Related content

Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Solid Organ Transplant Recipients

By Staatz Christine E.   Tett Susan E.  

Clinical Pharmacokinetics, Vol. 46, Iss. 1, 2007-01 ,pp. : 13-58

Adis International

Access to resources Recommend Favorite

Valganciclovir in Adult Solid Organ Transplant Recipients: Pharmacokinetic and Pharmacodynamic Characteristics and Clinical Interpretation of Plasma Concentration Measurements

By Perrottet Nancy  

Clinical Pharmacokinetics, Vol. 48, Iss. 6, 2009-06 ,pp. : 399-418

Adis International

Access to resources Recommend Favorite

Clinical Spectrum of Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma in Solid Organ Transplant Recipients: A Collective Experience

By McCoppin Holly H.   Christiansen Daniel   Stasko Thomas   Washington Carl   Martinez Juan Carlos   Brown Marc D.   Zwald Fiona O.  

Dermatologic Surgery, Vol. 38, Iss. 2, 2012-02 ,pp. : 230-239

Elsevier

Access to resources Recommend Favorite

Valganciclovir: therapeutic role in pediatric solid organ transplant recipients

By Yu Marie A   Park Jeong M  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 6, 2013-04 ,pp. : 807-815

Informa Healthcare

Access to resources Recommend Favorite

Valganciclovir for the prevention and treatment of CMV in solid organ transplant recipients

By Åsberg Anders   Rollag Halvor   Hartmann Anders  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1159-1166

Informa Healthcare

Access to resources Recommend Favorite